Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 285 entries
Sorted by: Best Match Show Resources per page
Assessing and improving data quality from community health workers: a successful intervention in Neno, Malawi.

Public health action

Admon AJ, Bazile J, Makungwa H, Chingoli MA, Hirschhorn LR, Peckarsky M, Rigodon J, Herce M, Chingoli F, Malani PN, Hedt-Gauthier BL.
PMID: 25767750
Public Health Action. 2013 Mar 21;3(1):56-59. doi: 10.5588/pha.12.0071.

SETTING: A community health worker (CHW) program was established in Neno District, Malawi, in 2007 by Partners In Health in support of Ministry of Health activities. Routinely generated CHW data provide critical information for program monitoring and evaluation. Informal...

Cite
Admon AJ, Bazile J, Makungwa H, et al. Assessing and improving data quality from community health workers: a successful intervention in Neno, Malawi. Public Health Action. 2013;3(1):56-59doi: 10.5588/pha.12.0071.
Admon, A. J., Bazile, J., Makungwa, H., Chingoli, M. A., Hirschhorn, L. R., Peckarsky, M., Rigodon, J., Herce, M., Chingoli, F., Malani, P. N., & Hedt-Gauthier, B. L. (2013). Assessing and improving data quality from community health workers: a successful intervention in Neno, Malawi. Public health action, 3(1), 56-59. https://doi.org/10.5588/pha.12.0071
Admon, A J, et al. "Assessing and improving data quality from community health workers: a successful intervention in Neno, Malawi." Public health action vol. 3,1 (2013): 56-59. doi: https://doi.org/10.5588/pha.12.0071
Admon AJ, Bazile J, Makungwa H, Chingoli MA, Hirschhorn LR, Peckarsky M, Rigodon J, Herce M, Chingoli F, Malani PN, Hedt-Gauthier BL. Assessing and improving data quality from community health workers: a successful intervention in Neno, Malawi. Public Health Action. 2013 Mar 21;3(1):56-59. doi: 10.5588/pha.12.0071. PMID: 25767750; PMCID: PMC4354657.
Copy Download .nbib Format: NLM
Practice patterns and perceptions of survivorship care in Canadian genitourinary oncology: A multidisciplinary perspective.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Almatar A, Richter S, Lalani N, Bender JL, Wiljer D, Alkazaz N, Legere L, Maganti M, Sridhar SS, Catton PP, Jewett MA.
PMID: 25553154
Can Urol Assoc J. 2014 Nov;8(11):409-17. doi: 10.5489/cuaj.2279.

INTRODUCTION: There is little knowledge of survivorship care specific to genitourinary (GU) cancers. To improve care delivery to this patient population, we need to clearly define physician perceptions of survivorship care. We therefore conducted a study to determine the...

Cite
Almatar A, Richter S, Lalani N, et al. Practice patterns and perceptions of survivorship care in Canadian genitourinary oncology: A multidisciplinary perspective. Can Urol Assoc J. 2014;8(11):409-17doi: 10.5489/cuaj.2279.
Almatar, A., Richter, S., Lalani, N., Bender, J. L., Wiljer, D., Alkazaz, N., Legere, L., Maganti, M., Sridhar, S. S., Catton, P. P., & Jewett, M. A. (2014). Practice patterns and perceptions of survivorship care in Canadian genitourinary oncology: A multidisciplinary perspective. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 8(11), 409-17. https://doi.org/10.5489/cuaj.2279
Almatar, Ashraf, et al. "Practice patterns and perceptions of survivorship care in Canadian genitourinary oncology: A multidisciplinary perspective." Canadian Urological Association journal = Journal de l'Association des urologues du Canada vol. 8,11 (2014): 409-17. doi: https://doi.org/10.5489/cuaj.2279
Almatar A, Richter S, Lalani N, Bender JL, Wiljer D, Alkazaz N, Legere L, Maganti M, Sridhar SS, Catton PP, Jewett MA. Practice patterns and perceptions of survivorship care in Canadian genitourinary oncology: A multidisciplinary perspective. Can Urol Assoc J. 2014 Nov;8(11):409-17. doi: 10.5489/cuaj.2279. PMID: 25553154; PMCID: PMC4277520.
Copy Download .nbib Format: NLM
Topographical expression of class IA and class II phosphoinositide 3-kinase enzymes in normal human tissues is consistent with a role in differentiation.

BMC clinical pathology

El Sheikh SS, Domin J, Tomtitchong P, Abel P, Stamp G, Lalani EN.
PMID: 14563213
BMC Clin Pathol. 2003 Oct 16;3(1):4. doi: 10.1186/1472-6890-3-4.

BACKGROUND: Growth factor, cytokine and chemokine-induced activation of PI3K enzymes constitutes the start of a complex signalling cascade, which ultimately mediates cellular activities such as proliferation, differentiation, chemotaxis, survival, trafficking, and glucose homeostasis. The PI3K enzyme family is divided...

Cite
El Sheikh SS, Domin J, Tomtitchong P, et al. Topographical expression of class IA and class II phosphoinositide 3-kinase enzymes in normal human tissues is consistent with a role in differentiation. BMC Clin Pathol. 2003;3(1):4doi: 10.1186/1472-6890-3-4.
El Sheikh, S. S., Domin, J., Tomtitchong, P., Abel, P., Stamp, G., & Lalani, E. N. (2003). Topographical expression of class IA and class II phosphoinositide 3-kinase enzymes in normal human tissues is consistent with a role in differentiation. BMC clinical pathology, 3(1), 4. https://doi.org/10.1186/1472-6890-3-4
El Sheikh, Soha Salama, et al. "Topographical expression of class IA and class II phosphoinositide 3-kinase enzymes in normal human tissues is consistent with a role in differentiation." BMC clinical pathology vol. 3,1 (2003): 4. doi: https://doi.org/10.1186/1472-6890-3-4
El Sheikh SS, Domin J, Tomtitchong P, Abel P, Stamp G, Lalani EN. Topographical expression of class IA and class II phosphoinositide 3-kinase enzymes in normal human tissues is consistent with a role in differentiation. BMC Clin Pathol. 2003 Oct 16;3(1):4. doi: 10.1186/1472-6890-3-4. PMID: 14563213; PMCID: PMC280660.
Copy Download .nbib Format: NLM
Molecular docking studies of banana flower flavonoids as insulin receptor tyrosine kinase activators as a cure for diabetes mellitus.

Bioinformation

Ganugapati J, Baldwa A, Lalani S.
PMID: 22493522
Bioinformation. 2012;8(5):216-20. doi: 10.6026/97320630008216. Epub 2012 Mar 17.

Diabetes mellitus is a metabolic disorder caused due to insulin deficiency. Banana flower is a rich source of flavonoids that exhibit anti diabetic activity. Insulin receptor is a tetramer that belongs to a family of receptor tyrosine kinases. It...

Cite
Ganugapati J, Baldwa A, Lalani S. Molecular docking studies of banana flower flavonoids as insulin receptor tyrosine kinase activators as a cure for diabetes mellitus. Bioinformation. 2012;8(5):216-20doi: 10.6026/97320630008216.
Ganugapati, J., Baldwa, A., & Lalani, S. (2012). Molecular docking studies of banana flower flavonoids as insulin receptor tyrosine kinase activators as a cure for diabetes mellitus. Bioinformation, 8(5), 216-20. https://doi.org/10.6026/97320630008216
Ganugapati, Jayasree, et al. "Molecular docking studies of banana flower flavonoids as insulin receptor tyrosine kinase activators as a cure for diabetes mellitus." Bioinformation vol. 8,5 (2012): 216-20. doi: https://doi.org/10.6026/97320630008216
Ganugapati J, Baldwa A, Lalani S. Molecular docking studies of banana flower flavonoids as insulin receptor tyrosine kinase activators as a cure for diabetes mellitus. Bioinformation. 2012;8(5):216-20. doi: 10.6026/97320630008216. Epub 2012 Mar 17. PMID: 22493522; PMCID: PMC3314874.
Copy Download .nbib Format: NLM
Difference in Early Activation of NF-κB and MCP-1 in Acinar-Cell-Rich versus Fibrotic Human Pancreas Exposed to Surgical Trauma and Hypoxia.

Gastroenterology research and practice

Laaninen M, Bläuer M, Sand J, Nordback I, Laukkarinen J.
PMID: 25147563
Gastroenterol Res Pract. 2014;2014:460363. doi: 10.1155/2014/460363. Epub 2014 Jul 24.

Objectives. Previously we have shown that a pancreas with over 40% acinar cells is exposed to postoperative pancreatitis and other complications after pancreaticoduodenectomy (PD). Our aim was to analyze the expression of NF-κB and MCP-1 in the cut edge...

Cite
Laaninen M, Bläuer M, Sand J, et al. Difference in Early Activation of NF-κB and MCP-1 in Acinar-Cell-Rich versus Fibrotic Human Pancreas Exposed to Surgical Trauma and Hypoxia. Gastroenterol Res Pract. 2014;2014:460363doi: 10.1155/2014/460363.
Laaninen, M., Bläuer, M., Sand, J., Nordback, I., & Laukkarinen, J. (2014). Difference in Early Activation of NF-κB and MCP-1 in Acinar-Cell-Rich versus Fibrotic Human Pancreas Exposed to Surgical Trauma and Hypoxia. Gastroenterology research and practice, 2014460363. https://doi.org/10.1155/2014/460363
Laaninen, Matias, et al. "Difference in Early Activation of NF-κB and MCP-1 in Acinar-Cell-Rich versus Fibrotic Human Pancreas Exposed to Surgical Trauma and Hypoxia." Gastroenterology research and practice vol. 2014 (2014): 460363. doi: https://doi.org/10.1155/2014/460363
Laaninen M, Bläuer M, Sand J, Nordback I, Laukkarinen J. Difference in Early Activation of NF-κB and MCP-1 in Acinar-Cell-Rich versus Fibrotic Human Pancreas Exposed to Surgical Trauma and Hypoxia. Gastroenterol Res Pract. 2014;2014:460363. doi: 10.1155/2014/460363. Epub 2014 Jul 24. PMID: 25147563; PMCID: PMC4131420.
Copy Download .nbib Format: NLM
Conceptual Barriers to Progress Within Evolutionary Biology.

Foundations of science

Laland KN, Odling-Smee J, Feldman MW, Kendal J.
PMID: 21572912
Found Sci. 2009 Aug;14(3):195-216. doi: 10.1007/s10699-008-9153-8.

In spite of its success, Neo-Darwinism is faced with major conceptual barriers to further progress, deriving directly from its metaphysical foundations. Most importantly, neo-Darwinism fails to recognize a fundamental cause of evolutionary change, "niche construction". This failure restricts the...

Cite
Laland KN, Odling-Smee J, Feldman MW, et al. Conceptual Barriers to Progress Within Evolutionary Biology. Found Sci. 2009;14(3):195-216doi: 10.1007/s10699-008-9153-8.
Laland, K. N., Odling-Smee, J., Feldman, M. W., & Kendal, J. (2009). Conceptual Barriers to Progress Within Evolutionary Biology. Foundations of science, 14(3), 195-216. https://doi.org/10.1007/s10699-008-9153-8
Laland, Kevin N, et al. "Conceptual Barriers to Progress Within Evolutionary Biology." Foundations of science vol. 14,3 (2009): 195-216. doi: https://doi.org/10.1007/s10699-008-9153-8
Laland KN, Odling-Smee J, Feldman MW, Kendal J. Conceptual Barriers to Progress Within Evolutionary Biology. Found Sci. 2009 Aug;14(3):195-216. doi: 10.1007/s10699-008-9153-8. PMID: 21572912; PMCID: PMC3093243.
Copy Download .nbib Format: NLM
Evaluation of homocysteine levels in patients with polycystic ovarian syndrome.

International journal of fertility & sterility

Salehpour S, Manzor-Al-Ajdad O, Samani EN, Abadi A.
PMID: 24851177
Int J Fertil Steril. 2011 Jan;4(4):168-71. Epub 2011 Feb 20.

BACKGROUND: To determine the level of plasma homocysteine in patients with polycystic ovary syndrome (PCOS) compared with healthy controls.MATERIALS AND METHODS: In this prospective case-control study on 85 PCOS women and 83 controls matched by body mass index (BMI),...

Cite
Salehpour S, Manzor-Al-Ajdad O, Samani EN, et al. Evaluation of homocysteine levels in patients with polycystic ovarian syndrome. Int J Fertil Steril. 2011;4(4):168-71
Salehpour, S., Manzor-Al-Ajdad, O., Samani, E. N., & Abadi, A. (2011). Evaluation of homocysteine levels in patients with polycystic ovarian syndrome. International journal of fertility & sterility, 4(4), 168-71.
Salehpour, Saghar, et al. "Evaluation of homocysteine levels in patients with polycystic ovarian syndrome." International journal of fertility & sterility vol. 4,4 (2011): 168-71.
Salehpour S, Manzor-Al-Ajdad O, Samani EN, Abadi A. Evaluation of homocysteine levels in patients with polycystic ovarian syndrome. Int J Fertil Steril. 2011 Jan;4(4):168-71. Epub 2011 Feb 20. PMID: 24851177; PMCID: PMC4023503.
Copy Download .nbib Format: NLM
Foraging innovation in the guppy.

Animal behaviour

Laland KN, Reader SM.
PMID: 10049472
Anim Behav. 1999 Feb;57(2):331-340. doi: 10.1006/anbe.1998.0967.

When novel behaviour patterns spread through animal populations, typically one animal will initiate the diffusion. It is not known whether such 'innovators' are particularly creative individuals, individuals exposed to the appropriate environmental contingencies, or individuals in a particular motivational...

Cite
Laland KN, Reader SM. Foraging innovation in the guppy. Anim Behav. 1999;57(2):331-340doi: 10.1006/anbe.1998.0967.
Laland, K. N., & Reader, S. M. (1999). Foraging innovation in the guppy. Animal behaviour, 57(2), 331-340. https://doi.org/10.1006/anbe.1998.0967
Laland, and Reader. "Foraging innovation in the guppy." Animal behaviour vol. 57,2 (1999): 331-340. doi: https://doi.org/10.1006/anbe.1998.0967
Laland KN, Reader SM. Foraging innovation in the guppy. Anim Behav. 1999 Feb;57(2):331-340. doi: 10.1006/anbe.1998.0967. PMID: 10049472.
Copy Download .nbib Format: NLM
Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature.

International journal of retina and vitreous

Chatziralli I, Vlachodimitropoulou A, Daoula C, Vrettou C, Galani E, Theodossiadis G, Theodossiadis P.
PMID: 30250750
Int J Retina Vitreous. 2018 Sep 19;4:33. doi: 10.1186/s40942-018-0137-8. eCollection 2018.

PURPOSE: The purpose of this review is to examine the role of eplerenone in the treatment of central serous chorioretinopathy (CSCR).METHODS: A comprehensive search of the PubMed database has been conducted regarding eplerenone for CSCR, while studies using spironolactone...

Cite
Chatziralli I, Vlachodimitropoulou A, Daoula C, et al. Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature. Int J Retina Vitreous. 2018;4:33doi: 10.1186/s40942-018-0137-8.
Chatziralli, I., Vlachodimitropoulou, A., Daoula, C., Vrettou, C., Galani, E., Theodossiadis, G., & Theodossiadis, P. (2018). Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature. International journal of retina and vitreous, 433. https://doi.org/10.1186/s40942-018-0137-8
Chatziralli, Irini, et al. "Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature." International journal of retina and vitreous vol. 4 (2018): 33. doi: https://doi.org/10.1186/s40942-018-0137-8
Chatziralli I, Vlachodimitropoulou A, Daoula C, Vrettou C, Galani E, Theodossiadis G, Theodossiadis P. Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature. Int J Retina Vitreous. 2018 Sep 19;4:33. doi: 10.1186/s40942-018-0137-8. eCollection 2018. PMID: 30250750; PMCID: PMC6145103.
Copy Download .nbib Format: NLM
[Neratinib + Valproate] exposure permanently reduces ERBB1 and RAS expression in 4T1 mammary tumors and enhances M1 macrophage infiltration.

Oncotarget

Booth L, Roberts JL, Rais R, Kirkwood J, Avogadri-Connors F, Cutler RE, Lalani AS, Poklepovic A, Dent P.
PMID: 29464055
Oncotarget. 2017 Dec 26;9(5):6062-6074. doi: 10.18632/oncotarget.23681. eCollection 2018 Jan 19.

The irreversible ERBB1/2/4 inhibitor neratinib has been shown

Cite
Booth L, Roberts JL, Rais R, et al. [Neratinib + Valproate] exposure permanently reduces ERBB1 and RAS expression in 4T1 mammary tumors and enhances M1 macrophage infiltration. Oncotarget. 2017;9(5):6062-6074doi: 10.18632/oncotarget.23681.
Booth, L., Roberts, J. L., Rais, R., Kirkwood, J., Avogadri-Connors, F., Cutler, R. E., Lalani, A. S., Poklepovic, A., & Dent, P. (2018). [Neratinib + Valproate] exposure permanently reduces ERBB1 and RAS expression in 4T1 mammary tumors and enhances M1 macrophage infiltration. Oncotarget, 9(5), 6062-6074. https://doi.org/10.18632/oncotarget.23681
Booth, Laurence, et al. "[Neratinib + Valproate] exposure permanently reduces ERBB1 and RAS expression in 4T1 mammary tumors and enhances M1 macrophage infiltration." Oncotarget vol. 9,5 (2018): 6062-6074. doi: https://doi.org/10.18632/oncotarget.23681
Booth L, Roberts JL, Rais R, Kirkwood J, Avogadri-Connors F, Cutler RE, Lalani AS, Poklepovic A, Dent P. [Neratinib + Valproate] exposure permanently reduces ERBB1 and RAS expression in 4T1 mammary tumors and enhances M1 macrophage infiltration. Oncotarget. 2017 Dec 26;9(5):6062-6074. doi: 10.18632/oncotarget.23681. eCollection 2018 Jan 19. PMID: 29464055; PMCID: PMC5814195.
Copy Download .nbib Format: NLM
Skull base or cervical vertebral osteomyelitis following chemoradiotherapy for pharyngeal carcinoma: A serious but treatable complication.

Clinical and translational radiation oncology

Lalani N, Huang SH, Rotstein C, Yu E, Irish J, O'Sullivan B.
PMID: 29594240
Clin Transl Radiat Oncol. 2017 Nov 21;8:40-44. doi: 10.1016/j.ctro.2017.11.005. eCollection 2018 Jan.

Osteomyelitis, infection of the bone and marrow, following high dose (chemo-)radiotherapy for head and neck cancer is uncommon and rarely seen in the cervical spine or temporal bone. Due to its proximity to critical structures, osteomyelitis in the latter...

Cite
Lalani N, Huang SH, Rotstein C, et al. Skull base or cervical vertebral osteomyelitis following chemoradiotherapy for pharyngeal carcinoma: A serious but treatable complication. Clin Transl Radiat Oncol. 2017;8:40-44doi: 10.1016/j.ctro.2017.11.005.
Lalani, N., Huang, S. H., Rotstein, C., Yu, E., Irish, J., & O'Sullivan, B. (2018). Skull base or cervical vertebral osteomyelitis following chemoradiotherapy for pharyngeal carcinoma: A serious but treatable complication. Clinical and translational radiation oncology, 840-44. https://doi.org/10.1016/j.ctro.2017.11.005
Lalani, Nafisha, et al. "Skull base or cervical vertebral osteomyelitis following chemoradiotherapy for pharyngeal carcinoma: A serious but treatable complication." Clinical and translational radiation oncology vol. 8 (2018): 40-44. doi: https://doi.org/10.1016/j.ctro.2017.11.005
Lalani N, Huang SH, Rotstein C, Yu E, Irish J, O'Sullivan B. Skull base or cervical vertebral osteomyelitis following chemoradiotherapy for pharyngeal carcinoma: A serious but treatable complication. Clin Transl Radiat Oncol. 2017 Nov 21;8:40-44. doi: 10.1016/j.ctro.2017.11.005. eCollection 2018 Jan. PMID: 29594240; PMCID: PMC5862672.
Copy Download .nbib Format: NLM
Infectious Diseases Mortality in the United States: Ongoing Investment Needed for Continued Progress.

JAMA

Shuman EK, Malani PN.
PMID: 29584824
JAMA. 2018 Mar 27;319(12):1205-1206. doi: 10.1001/jama.2018.1525.

No abstract available.

Cite
Shuman EK, Malani PN. Infectious Diseases Mortality in the United States: Ongoing Investment Needed for Continued Progress. JAMA. 2018;319(12):1205-1206doi: 10.1001/jama.2018.1525.
Shuman, E. K., & Malani, P. N. (2018). Infectious Diseases Mortality in the United States: Ongoing Investment Needed for Continued Progress. JAMA, 319(12), 1205-1206. https://doi.org/10.1001/jama.2018.1525
Shuman, Emily K, and Malani, Preeti N. "Infectious Diseases Mortality in the United States: Ongoing Investment Needed for Continued Progress." JAMA vol. 319,12 (2018): 1205-1206. doi: https://doi.org/10.1001/jama.2018.1525
Shuman EK, Malani PN. Infectious Diseases Mortality in the United States: Ongoing Investment Needed for Continued Progress. JAMA. 2018 Mar 27;319(12):1205-1206. doi: 10.1001/jama.2018.1525. PMID: 29584824.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 285 entries